These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 9323089)

  • 1. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.
    Oie E; Bjønerheim R; Grogaard HK; Kongshaug H; Smiseth OA; Attramadal H
    Am J Physiol; 1998 Sep; 275(3):H868-77. PubMed ID: 9724291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
    Fraccarollo D; Hu K; Galuppo P; Gaudron P; Ertl G
    Circulation; 1997 Dec; 96(11):3963-73. PubMed ID: 9403621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
    Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
    Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
    Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
    Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
    Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
    Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure.
    Iwanaga Y; Kihara Y; Inagaki K; Onozawa Y; Yoneda T; Kataoka K; Sasayama S
    Circulation; 2001 Jul; 104(5):606-12. PubMed ID: 11479261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats.
    Oie E; Yndestad A; Robins SP; Børnerheim R; Asberg A; Attramadal H
    Basic Res Cardiol; 2002 May; 97(3):239-47. PubMed ID: 12061394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure.
    Shimoyama H; Sabbah HN; Borzak S; Tanimura M; Shevlyagin S; Scicli G; Goldstein S
    Circulation; 1996 Aug; 94(4):779-84. PubMed ID: 8772702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
    Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
    Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.
    Iwanaga Y; Kihara Y; Hasegawa K; Inagaki K; Yoneda T; Kaburagi S; Araki M; Sasayama S
    Circulation; 1998 Nov; 98(19):2065-73. PubMed ID: 9808606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs.
    Choussat R; Hittinger L; Barbe F; Maistre G; Carayon A; Crozatier B; Su J
    Cardiovasc Res; 1998 Sep; 39(3):580-8. PubMed ID: 9861300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
    Richard V; Hogie M; Thuillez C
    Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
    Lee TM; Chen CC; Lin MS; Chang NC
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats.
    Murray DB; Gardner JD; Brower GL; Janicki JS
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1251-7. PubMed ID: 18178727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.
    Fraccarollo D; Bauersachs J; Kellner M; Galuppo P; Ertl G
    Cardiovasc Res; 2002 Apr; 54(1):85-94. PubMed ID: 12062365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin antagonism in experimental ischemic heart failure: hemodynamic, structural and neurohumoral effects.
    Mulder P; Richard V; Thuillez C
    Heart Fail Rev; 2001 Dec; 6(4):295-300. PubMed ID: 11447304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.
    Ding SS; Qiu C; Hess P; Xi JF; Clozel JP; Clozel M
    Cardiovasc Res; 2002 Mar; 53(4):963-70. PubMed ID: 11922906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.
    Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O
    Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.